Navigation Links
Queensland technology licensed by billion-dollar US company
Date:2/15/2008

University of Queensland scientists have developed a proprietary technology that will help other researchers in understanding fundamental aspects of growth, development, and disease, which has been licensed to one of the world's largest life science technology companies.

Dr Marcel Dinger and Professor John Mattick, from UQ's Institute for Molecular Bioscience, have designed a new type of microarray RNA chip, used by researchers to analyse which genes are being expressed at any one time in a particular cell.

The technology has been licensed through IMBcom, UQ's company for the commercialisation of intellectual property arising from research conducted at the IMB. It was licensed to Invitrogen, a provider of essential life science technologies for research, production and diagnostics with a 2006 revenue of US$1.15 billion.

Every cell in the body contains a full set of genes, but different cells express different subsets, Professor Mattick said. In the past these genes were thought only to code mainly for proteins, via the production of "messenger RNAs", but it is now evident that many other genes produce non-coding RNAs whose functions have yet to be determined.

It appears that we have misunderstood the nature of genetic programming in humans and other complex organisms, Professor Mattick said. Most of the genome is transcribed, mainly into non-coding RNAs, which appear to comprise a hidden layer of gene regulation whose full dimensions are just beginning to be explored.

There is increasing recognition that these non-coding RNAs control various levels of gene expression in physiology and development, as well as in the brain.

Products commercialized by Invitrogen will be based on a novel set of RNA probes that Dr Dinger and Professor Mattick have designed, which can uniquely identify tens of thousands of coding and non-coding RNA sequences. This is the first time that one product has been able to identify both large number
'/>"/>

Contact: Bronwyn Adams
communications@uq.edu.au
61-733-462-134
Research Australia
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Fluoridated water for Queensland ... at last
2. Queensland businessman is one in a million
3. QueensLander Tours Presents an Adventure Boot Camp Cruise with John Spencer Ellis from Bravos The Real Housewives of Orange County
4. Quantum light beams good for fast technology
5. New Smart Technology Makes Patient Data Collection Easier, More Efficient
6. Align Technology Executive to Present at Upcoming Financial Conferences
7. Pioneer Surgical Technology Hires Vice President of New Business Development
8. Purdue researchers develop technology to detect cancer by scanning surface veins
9. Creative Technology Services Enhances its Global Competitiveness with Additional Regulatory Certifications
10. University of Wisconsin Hospitals and Clinics Complete System-Wide Conversion to Masimo SET Pulse Oximetry Technology
11. Patent Reform Legislation Threatens Americas Leadership in Medical Technology Innovation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...27 The Gymboree Corporat... CFO/COO, will present at the NASDAQ OMX 23rd Inve...otel in London, England, on Wednesday, December 2,...e broadcast of The Gymboree Corporation,s presenta...ree.com, click on "Our Company" at the bottom of t...
(Date:11/27/2009)...ission vehicles may reduce future disease burden, ...lthDay News) -- Encouraging city dwellers to walk ... greater public health benefits than increased use...found. , The study compared the projected healt...ort scenarios for London, England, and Delhi, Indi...
(Date:11/27/2009)...alist manufacturers who use medical load cells at ... dollars by bringing in technology partner Flintec...f pro-active medical manufacturers are calling in ...their projects, ensuring that progress will not be...tially outdated technology. , ...
(Date:11/26/2009)...tetrathiomolybdate (TM) has been shown in studies ..., a disease caused by an overload of copper, and c...y little, however, is known about how the drug wor...Northwestern University researchers now has provid...ture of TM bound to copper-loaded metallochaperone...
(Date:11/26/2009)...rch Triangle Dental (RTDental), a leading dental g...ounced the expansion of its services to include LU...Macmillan. , Durham, N...o announce that Dr. Doug Macmillan, an experienced...onal advanced training seminar. RTDental’s ...
Breaking Medicine News(10 mins):Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2
... Plan of Action on Behalf of their Client, Joel, ...Services, Inc. and its ...ry,s law firm announced,today that they have filed...pose the misconduct and wrongdoings of,Durham Coun...
...EP MEDICATIONS , Insomnia occurs when people ha...t is a common sleep compliant. While a brief case ...itement or other emotion, more than 20 million Ame...nd often debilitating condition, can lead to sever...
... January 23, 2008RNA interference (RNAi) represent...olecules to silence specific genes associated with...s describing the state-of-the-art and potential th...a peer-reviewed journal published by Mary Ann Lieb...
...23 University students in America,are turning to ...whelming,numbers to boost their focus, stay up lat...scribed for Attention Deficit Hyperactivity Disord...,coveted drugs are no longer illegal, mind-alterin...
...uccess at European Patent Hearing is Confirmed by ...NBURGH, Scotland, January 23 The European Patent,...(the ,131, patent) not,valid as granted. In a ruli...ncing the EPO ruling as a success, despite the,fac...
...ow to Fight Premature Birth in Ohio, COLUMBUS, Oh... rate of premature birth is up once again from 12....erm births were recorded for,2005 and over 20 lawm...non-partisan caucus to increase awareness of,the s...
Other Medicine News:Health News:The Willie Gary Law Firm Files $1 Billion Lawsuit Against Durham County LME, Wake County LME, Five County LME, Mecklenberg County LME and Value Options, Inc. for Negligent and Intentional Misconduct Against Mental Health Agency 2Health News:AASM statement on use of sleep medications 2Health News:AASM statement on use of sleep medications 3Health News:The RNA drug revolution -- a new approach to gene therapy 2Health News:Prescription 'Mind Meds' Pose Dangerous Threat to College Students 2Health News:Aircraft Medical: European Patent Hearing 2Health News:Ohio Prematurity Caucus Forming to Meet Challenge 2Health News:Ohio Prematurity Caucus Forming to Meet Challenge 3
(Date:11/24/2009)...BURGH, Nov. 24 ,, WHAT: Rom H... for 23 years following an auto accident, was actu...d was the subject of a Good Morning America segmen... to illustrate how people with Locked-in Syndrome ..., WHEN: Good Morning America -- Tuesday, Novemb...
(Date:11/24/2009)...ISON, N.J., Nov. 24 Ques...ld,s leading provider of diagnostic testing, infor...d to speak at the 21st Annual Piper Jaffray Health...n is scheduled for Wednesday, December 2, 2009 at ...e, the company will reaffirm its 2009 guidance for...
(Date:11/24/2009)...EGO, Nov. 24 Anadys Phar... that it will present at the 21st Annual Piper Jaf... 2009 at 9:00 a.m. EST (6:00 a.m. PST). The confe... Steve Worland, Ph.D., President and Chief Executi...Anadys and its clinical development programs, ANA5...
Breaking Medicine Technology:DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Amgen Named Presenting Sponsor of The Dempsey Challenge 3A A Journey For Hope 56650 1Amgen Named Presenting Sponsor of The Dempsey Challenge 3A A Journey For Hope 56650 2Amgen Named Presenting Sponsor of The Dempsey Challenge 3A A Journey For Hope 56650 3Amgen Named Presenting Sponsor of The Dempsey Challenge 3A A Journey For Hope 56650 4Ancient oceans offer new insight into the origins of animal life 9852 1Ancient oceans offer new insight into the origins of animal life 9852 249th ICAAC press kit now available online 9848 1
... Response or Reduction of,Lesion Size by More than...RNewswire-FirstCall/ - Nventa,Biopharmaceuticals C...itive results from a clinical trial examining the ...estigational therapeutic,vaccine for human papillo...highest grade of cervical dysplasia (CIN III). The...
...7 - Accentia,Biopharmaceuticals, Inc. (NASDAQ: ABP...of the American Academy of Allergy, Asthma, and,Im... CA. The,posters discussed findings from a survey ...the U.S., U.K., France, and Germany on the,burden ...udes of,the fungal etiology of CS, and the differe...
Other Medicine Technology:Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 2Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 3Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 4Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 5Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 6Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology 2Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology 3Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology 4Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology 5
8.00mm Open Trephine Handle
Retinal Forceps: Smooth 1.0mm Tips, Vertical Action
Gass Retinal Detachment Hook, Flattened 13mm Fenestrated
Schockett Double Ended Depressor w/Clip
Medicine Products: